Business Context and Reporting Period
Company: Unifirst Corp.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Twenty-seven weeks ended March 2, 2002 (Fiscal 2002).
Business Overview: The Company provides uniform rental, first aid, and nuclear garment services. Results are subject to seasonality and economic conditions.
Key Financial Metrics
| Metric | 27 Weeks Ended Mar 2, 2002 | 26 Weeks Ended Feb 24, 2001 |
|---|---|---|
| Revenues | $294.1 million | $277.6 million |
| Net Income | $12.8 million | $11.1 million |
| Diluted EPS | $0.66 | $0.57 |
| Operating Cash Flow | $31.7 million | $33.1 million |
| Operating Margin | 8.8% | 8.7% |
| Net Margin | 4.3% | 4.0% |
| Total Debt (Current + Long-term) | $83.2 million | $94.8 million |
| Cash and Equivalents | $6.0 million | $6.1 million |
| Shareholders' Equity | $296.8 million | $285.5 million |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 6.0% ($16.6 million) driven by an extra week in the current period (4.0%), growth in nuclear garment services (1.3%), and organic growth/price increases (0.7%).
- Operating Costs: Increased to $177.9 million but improved as a percentage of revenue (60.5% vs. 61.9%) due to lower merchandise costs from in-plant stockrooms and reduced energy costs.
- Selling & Administrative Expenses: Increased to $71.8 million (24.4% of revenue) from $62.9 million (22.7% of revenue). The prior year was favorably impacted by a $1.1 million lawsuit settlement. Current increases are due to sales force expansion and higher health care costs.
- Depreciation & Amortization: Decreased to $18.5 million primarily due to the adoption of SFAS No. 142, which eliminated goodwill amortization.
- Other Expense: Net other expense was $5.3 million, including a $2.3 million estimated interest charge related to an IRS revenue agent review settlement.
Guidance, Outlook, and Risks
- IRS Settlement: Management expects to pay approximately $15 million by August 2002 to settle a revenue agent review with the IRS. A $2.3 million interest charge was recorded in the current period.
- Liquidity: The Company holds $6.0 million in cash and has $79.0 million available under a $170 million unsecured line of credit. Management believes cash flow and borrowing capacity are sufficient for foreseeable needs.
- Accounting Changes: Adoption of SFAS No. 142 (Goodwill) and SFAS No. 133 (Derivatives) impacts reported earnings and comprehensive income. Future adoption of SFAS No. 143 (Asset Retirement Obligations) and SFAS No. 144 (Impairment) is pending.
- Risks: Key risks include economic conditions, fluctuations in material/fuel/labor costs, the impact of the war on terrorism, and the outcome of pending litigation. The Company does not hedge foreign currency risk.
Investor Verification Checklist
- Verify the timing and final amount of the $15 million IRS settlement payment expected by August 2002.
- Monitor the impact of the $2.3 million interest charge on future cash flows and effective tax rates.
- Assess the sustainability of operating cost improvements (60.5% of revenue) given rising health care costs.
- Review the utilization of the $170 million credit line and debt repayment schedule.
- Confirm the impact of SFAS No. 142 on future earnings comparisons, as goodwill amortization has ceased.